{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lin YH"],"funding":["Ministry of Science and Technology"],"pagination":["1169-1181"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9807465"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["30(2)"],"pubmed_abstract":["Background
To cure advanced hypopharyngeal squamous cell carcinoma (HPSCC), primary operation followed by adjuvant (chemo-)radiotherapy (OP-CRT) or definitive chemoradiation (CCRT) are the two primary options. This study aimed to compare the failure patterns and long-term survival outcomes of HPSCC patients treated with these two strategies. PATIENTS AND METHODS: From 2007 to 2015, 198 pathologically confirmed HPSCC patients receiving either OP-CRT or CCRT were retrospectively reviewed. Failure patterns and survival outcomes stratified by the 7th American Joint Committee on Cancer staging system and treatment modalities were compared.Results
One hundred and eighty-nine patients (95.4%) were stage III/IV and 62 patients (31.3%) received OP-CRT. Median follow-up duration was "],"journal":["Annals of surgical oncology"],"pubmed_title":["Distinct Failure Patterns in Hypopharyngeal Cancer Patients Receiving Surgery-Based Versus Radiation-Based Treatment."],"pmcid":["PMC9807465"],"funding_grant_id":["MOST 109-2314-B-006-096"],"pubmed_authors":["Huang CC","Yen CJ","Hsiao JR","Lai YH","Jiang SS","Wu YH","Chang JS","Su YC","Chang CC","Lin CL","Lin YH","Tsai ST","Hsueh WT","Chen YS","Wu SY","Ou CY","Lee WT"],"additional_accession":[]},"is_claimable":false,"name":"Distinct Failure Patterns in Hypopharyngeal Cancer Patients Receiving Surgery-Based Versus Radiation-Based Treatment.","description":"Background
To cure advanced hypopharyngeal squamous cell carcinoma (HPSCC), primary operation followed by adjuvant (chemo-)radiotherapy (OP-CRT) or definitive chemoradiation (CCRT) are the two primary options. This study aimed to compare the failure patterns and long-term survival outcomes of HPSCC patients treated with these two strategies. PATIENTS AND METHODS: From 2007 to 2015, 198 pathologically confirmed HPSCC patients receiving either OP-CRT or CCRT were retrospectively reviewed. Failure patterns and survival outcomes stratified by the 7th American Joint Committee on Cancer staging system and treatment modalities were compared.Results
One hundred and eighty-nine patients (95.4%) were stage III/IV and 62 patients (31.3%) received OP-CRT. Median follow-up duration was ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-05T12:09:47.301Z","creation":"2024-11-13T01:34:02.696Z"},"accession":"S-EPMC9807465","cross_references":{"pubmed":["36336733"],"doi":["10.1245/s10434-022-12744-1"]}}